Abstract
Objectives: The goal of this study is to determine if the use of Cidofovir injected locally reduces the number of debulking procedures on pediatric patients with recurrente respiratory papillomatosis.
Methods: We injected 37.5 mg of Cidofovir intralesionaly in each patient with a laryngeal gauze 27, each 3 weeks for a total of 5 times on each patients. In each patients Hematic count, Hepatic enzymes, and BUN in each patient was done 1 week after and 1 week before each injection.
Results: We included 7 patients in a 18-month period, 6 of the 7 patients have not needed a debulking procedure in the last 10 months, the obstruction and voice improved, 1 of the patients needed 3 more injections, and has not needed another debulking procedure in the last 3 months; none of the patients had any laboratory alteration.
Conclusion: Cidofovir is a drug effective in the treatment of recurrent respiratory papillomatosis, probably reducing the papilomatosis activity in the laringeal tissue.
Get full access to this article
View all access options for this article.